PMID- 18975529 OWN - NLM STAT- MEDLINE DCOM- 20081209 LR - 20131121 IS - 1028-768X (Print) IS - 1028-768X (Linking) VI - 17 IP - 3 DP - 2008 Sep TI - [Charcot-Marie-Tooth disease]. PG - 203-13 AB - Charcot-Marie-Tooth disease (CMT), also called hereditary motor and sensory neuropathy (HMSN), is the most common inherited peripheral neuropathy, comprised by a group of genetically heterogeneous disorders that share clinical characteristics of progressive distal muscle weakness and atrophy, foot deformities, distal sensory loss, and depressed tendon reflexes. It can be categorized according to its electrophysiological or pathological features, transmission patterns, age of disease onset, and molecular pathology. CMT type 1 (CMT1; MIM 118200) is a group of autosomal dominant-inherited demyelinating neuropathies with a disease onset at or after childhood. Five different subtypes have been identified based on different causative genes. Among them, CMT1A (MIM #118220) is most common and is usually associated with a duplication of a 1.5-Mb region on chromosome 17p11.2, which includes peripheral myelin protein 22 gene (PMP22; MIM *601097). Currently, there is no cure or obviously effective disease-modifying treatment for CMT. Two potential effective therapeutic agents for CMT1A were investigated recently. One is ascorbic acid and another is neurotrophin-3 (NT-3), an important component of the Schwann cell autocrine survival loop. Early diagnosis can facilitate CMT patients to modify their life styles timely for minimizing nerve injury to delay or avoid disability. Molecular diagnosis of CMT can provide the basis for appropriate genetic counseling and further CMT research. FAU - Lee, Yi-Chung AU - Lee YC AD - Section of Neurology, Taichung Veterans General Hospital, Taichung, Taiwan. yclee@vghtc.gov.tw FAU - Chang, Ming-Hon AU - Chang MH FAU - Lin, Kon-Ping AU - Lin KP LA - chi PT - English Abstract PT - Journal Article PT - Review PL - China (Republic : 1949- ) TA - Acta Neurol Taiwan JT - Acta neurologica Taiwanica JID - 9815355 RN - PQ6CK8PD0R (Ascorbic Acid) SB - IM MH - Animals MH - Ascorbic Acid/therapeutic use MH - Charcot-Marie-Tooth Disease/classification/etiology/*genetics/therapy MH - Disease Models, Animal MH - Humans RF - 84 EDAT- 2008/11/04 09:00 MHDA- 2008/12/17 09:00 CRDT- 2008/11/04 09:00 PHST- 2008/11/04 09:00 [pubmed] PHST- 2008/12/17 09:00 [medline] PHST- 2008/11/04 09:00 [entrez] PST - ppublish SO - Acta Neurol Taiwan. 2008 Sep;17(3):203-13.